Stay updated on Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.
Latest updates to the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check8 days agoChange DetectedThe website has updated its list of principal investigators, removing previous entries and adding new ones, while also changing the version from v2.13.3 to v2.14.0.SummaryDifference49%
- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check37 days agoChange DetectedThe website has been updated from version 2.13.0 to 2.13.2, indicating new features or improvements.SummaryDifference0.0%
- Check44 days agoChange DetectedThe website has updated the contact details section for the study, now providing clearer information on who to contact for questions and where the study is taking place, reflecting a revision from v2.12.2 to v2.13.0.SummaryDifference1%
- Check51 days agoChange DetectedSeveral key resources related to idiopathic pulmonary fibrosis and other genetic conditions have been removed from the website, including links to MedlinePlus and NIH, which may impact access to important health information.SummaryDifference2%
Stay in the know with updates to Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.